Researchers at the University of Southampton might find a way to reduce the memory problems associated with Alzheimer’s disease. The discovery has translated into a drug that has been effective with mice. The drug, still highly experimental, works by blocking the neurological receptor CSF1R, which regulates the immune cells known as microglia. Tissue samples taken from brains of Alzheimer’s patients have been shown to contain more microglia than healthy brain tissue. Study author:
These findings are as close to evidence as we can get to show that this particular pathway is active in the development of Alzheimer’s disease.